4

De-escalating treatment in the adjuvant setting in HER2-positive breast cancer

Année:
2018
Langue:
english
Fichier:
PDF, 1.28 MB
english, 2018
5

Abemaciclib for the treatment of HR+/HER2- breast cancer

Année:
2018
Langue:
english
Fichier:
PDF, 1.08 MB
english, 2018
9

Follow-up care of patients with breast cancer

Année:
2007
Langue:
english
Fichier:
PDF, 150 KB
english, 2007
10

Lymphopenia Associated with Adjuvant Anthracycline/Taxane Regimens

Année:
2008
Langue:
english
Fichier:
PDF, 110 KB
english, 2008
15

New HER2-Positive Targeting Agents in Clinical Practice

Année:
2014
Langue:
english
Fichier:
PDF, 168 KB
english, 2014
22

The evolving understanding of small HER2-positive breast cancers: matching management to outcomes

Année:
2015
Langue:
english
Fichier:
PDF, 1.74 MB
english, 2015
24

Optimizing the Management of Metastatic HER2-Positive Breast Cancer

Année:
2015
Langue:
english
Fichier:
PDF, 859 KB
english, 2015
43

Optimal treatment of early stage HER2-positive breast cancer

Année:
2018
Langue:
english
Fichier:
PDF, 614 KB
english, 2018
50

Evidence to date: talazoparib in the treatment of breast cancer

Année:
2019
Langue:
english
Fichier:
PDF, 291 KB
english, 2019